Deteriorating post op patient with type two heart failure, stage 4 kidney disease on dialysis - Nursing Case Study

Pathophysiology

• Primary mechanism: Fluid Overload - Type 2 heart failure impairs the heart's ability to pump efficiently, leading to fluid accumulation. In stage 4 kidney disease, the kidneys are unable to excrete sufficient fluid, exacerbating congestion and causing pulmonary edema and peripheral edema.

• Secondary mechanism: Electrolyte Imbalance - Dialysis in kidney disease can cause rapid shifts in electrolytes, particularly potassium and calcium. These imbalances can destabilize cardiac function, potentially leading to arrhythmias, further compromising heart efficiency and perfusion.

• Key complication: Reduced Perfusion - The combined effects of heart failure and kidney dysfunction lead to decreased cardiac output and inadequate renal perfusion. This perpetuates a cycle of worsening heart and kidney function, increasing the risk for multi-organ failure, necessitating vigilant monitoring and intervention.

Patient Profile

Demographics:

68-year-old male, retired construction worker

History:

• Key past medical history: Type 2 heart failure diagnosed 5 years ago, stage 4 chronic kidney disease on dialysis for 2 years, hypertension, type 2 diabetes, previous myocardial infarction

• Current medications: Lisinopril, Metoprolol, Furosemide, Insulin, Erythropoietin, Sevelamer

• Allergies: Penicillin, shellfish

Current Presentation:

• Chief complaint: Severe shortness of breath and chest pain post-surgery

• Key symptoms: Dyspnea, fatigue, peripheral edema, decreased urine output, confusion

• Vital signs: Blood pressure 88/54 mmHg, heart rate 118 bpm, respiratory rate 28 breaths per minute, temperature 101.2°F, oxygen saturation 82% on room air

Section 1

As the clinical team continues their assessment of the 68-year-old patient, they note several critical changes indicating a deterioration in his condition. The patient’s shortness of breath worsens, and his oxygen saturation remains critically low at 79% despite supplemental oxygen via a non-rebreather mask. Auscultation reveals bilateral crackles in the lung bases, consistent with pulmonary edema, and the presence of a new S3 heart sound suggests worsening heart failure. Peripheral pulses are weak and thready, and capillary refill is delayed, highlighting significant circulatory compromise.

Laboratory results return, showing alarming electrolyte imbalances. The patient's potassium level is elevated at 6.3 mEq/L, which poses a risk for life-threatening cardiac arrhythmias. Additionally, his serum creatinine is markedly increased at 6.5 mg/dL, indicating severe renal impairment and inadequate dialysis clearance. These findings are compounded by a low hemoglobin level of 8.1 g/dL, suggesting anemia of chronic disease, which further diminishes his oxygen-carrying capacity and exacerbates tissue hypoxia. Arterial blood gas analysis reveals a mixed respiratory and metabolic acidosis with a pH of 7.28, PaCO2 of 58 mmHg, and HCO3- of 18 mEq/L.

In response to these critical findings, the healthcare team initiates immediate interventions aimed at stabilizing the patient. Intravenous calcium gluconate is administered to counteract the effects of hyperkalemia on cardiac function. Continuous renal replacement therapy (CRRT) is considered to urgently address the fluid overload and correct electrolyte imbalances. Despite these measures, the patient becomes increasingly confused and agitated, indicating possible cerebral hypoperfusion or uremic encephalopathy. As the team prepares for potential intubation and mechanical ventilation, they must continuously re-evaluate the patient’s response to interventions, considering the need for advanced hemodynamic support and consultation with nephrology and cardiology specialists.

Section 2

As the healthcare team continues to manage the patient's rapidly deteriorating condition, they monitor his response to the initial interventions. Despite the administration of intravenous calcium gluconate and initiation of continuous renal replacement therapy (CRRT), the patient shows minimal improvement. His oxygen saturation remains critically low, fluctuating between 80-82% even with high-flow oxygen, and his respiratory effort becomes increasingly labored. The team observes a further decline in mental status, with the patient becoming more lethargic and intermittently unresponsive, raising concerns of worsening cerebral hypoperfusion or possible progression to acute respiratory failure.

A repeat set of laboratory tests reveals persistent hyperkalemia with a potassium level stubbornly at 6.1 mEq/L, indicating inadequate clearance despite CRRT. The blood gas analysis shows a slight worsening in acidosis, with a pH now at 7.26, PaCO2 at 60 mmHg, and HCO3- at 17 mEq/L, suggesting deteriorating respiratory compensation. Additionally, the patient's lactate level is elevated at 4.5 mmol/L, pointing towards systemic hypoperfusion and possible septic physiology. The nursing team notes a drop in blood pressure to 85/50 mmHg, with a heart rate climbing to 120 beats per minute, indicating potential septic shock or cardiogenic shock due to combined cardiac and renal failure.

Recognizing the urgency of the situation, the team decides to intubate the patient to secure the airway and allow for controlled ventilation. Vasopressor support is initiated with norepinephrine to stabilize blood pressure and improve perfusion to vital organs. Consultations with nephrology and cardiology are expedited to reassess the patient's management plan, focusing on optimizing hemodynamic stability and addressing the multifaceted challenges posed by his concurrent heart and kidney failure. The team prepares for potential additional interventions, including escalation of renal support and advanced cardiac monitoring, while continuously evaluating the patient's response to treatment and potential for recovery amidst his complex clinical picture.

Section 3

As the team moves swiftly to intubate the patient, they note a marked decrease in respiratory effort, with shallow breaths and significantly reduced chest excursion. The rapid sequence intubation is performed without complications, and the patient is connected to mechanical ventilation with settings adjusted to correct the acidosis and improve oxygenation. Initial ventilator settings include a tidal volume of 6 ml/kg, a respiratory rate of 20 breaths per minute, and a FiO2 of 100%. However, despite these adjustments, the patient's arterial blood gas post-intubation shows persistent respiratory acidosis with a pH of 7.22, PaCO2 of 65 mmHg, and PaO2 of 58 mmHg, indicating inadequate ventilation and a need for further ventilatory strategy optimization.

A repeat assessment reveals new crackles in the lung fields upon auscultation, and the patient's jugular venous distention is more pronounced, suggesting worsening heart failure or fluid overload. The team also notices cool extremities and delayed capillary refill, further emphasizing the severity of his hemodynamic instability. A 12-lead ECG is obtained, which shows sinus tachycardia with diffuse ST-segment depression, raising concerns for myocardial ischemia possibly exacerbated by the patient's existing type two heart failure and the stress of systemic hypoperfusion.

In response to these findings, the team considers adjusting the CRRT settings to enhance fluid removal and better manage the patient's volume status. The nephrologist recommends increasing the ultrafiltration rate cautiously, given the risk of further compromising cardiac output. Meanwhile, cardiology suggests the potential initiation of dobutamine in addition to norepinephrine to support cardiac contractility and improve the forward flow, which may assist in alleviating pulmonary congestion. As the team proceeds with these interventions, they remain vigilant, continuously reassessing the patient’s hemodynamic parameters and ventilatory status to guide further therapeutic decisions, ever aware of the precarious balance required to navigate the complexities of his intertwined cardiac and renal failure.

Section 4

As the interventions are implemented, the patient's hemodynamic status is closely monitored. Despite the cautious increase in ultrafiltration and the introduction of dobutamine alongside norepinephrine, the patient exhibits signs of worsening hemodynamic instability. Blood pressure readings become labile, with systolic pressures fluctuating between 80-110 mmHg, and the heart rate remains elevated at 120-130 beats per minute, suggesting ongoing sympathetic compensation. The repeated assessment reveals persistent jugular venous distention, and crackles have intensified in the lung fields, indicating that pulmonary congestion is not yet adequately relieved.

Further complicating the scenario, new laboratory results return, revealing a serum potassium level of 6.3 mmol/L, likely secondary to compromised renal function and acidosis. The elevated potassium level poses an immediate risk for cardiac arrhythmias, necessitating urgent intervention. The team initiates calcium gluconate to stabilize cardiac membranes, along with insulin and glucose to facilitate intracellular potassium shift, while considering additional dialysis adjustments to enhance potassium clearance.

Despite these aggressive measures, the patient's condition takes another turn as a sudden drop in oxygen saturation to 84% on 100% FiO2 raises alarms. A repeat chest X-ray is quickly obtained, revealing new bilateral infiltrates suggestive of acute respiratory distress syndrome (ARDS), potentially triggered by ongoing inflammatory processes or fluid shifts. The team recognizes the need for an adjustment in ventilatory strategy, considering the use of higher positive end-expiratory pressure (PEEP) to recruit atelectatic lung areas and improve oxygenation, while carefully balancing the risk of exacerbating hemodynamic compromise. As the team navigates these complex challenges, they prepare for potential escalation of care, including consultation for advanced therapies such as extracorporeal membrane oxygenation (ECMO), should conventional measures fail to stabilize the patient.

Section 5

As the team continues to manage the escalating complexities of the case, a change in the patient's status becomes evident. While implementing increased PEEP to improve oxygenation, the patient's hemodynamic status deteriorates further. Blood pressure readings drop to a concerning 70/40 mmHg, and the heart rate spikes to 140 beats per minute, suggesting severe cardiovascular compromise. Despite the administration of vasopressors, the patient exhibits signs of reduced perfusion, with cool extremities and delayed capillary refill time, raising concerns about impending shock.

Amidst these changes, the patient's neurological status also declines; he becomes increasingly lethargic and minimally responsive to verbal stimuli, potentially indicating cerebral hypoperfusion. A rapid arterial blood gas analysis reveals a mixed metabolic and respiratory acidosis, with a pH of 7.18, pCO2 of 55 mmHg, and HCO3- of 18 mmol/L. The elevated blood urea nitrogen (BUN) and creatinine levels signal worsening renal function, while lactate levels surge to 5.6 mmol/L, indicating significant tissue hypoxia.

Given these critical developments, the interdisciplinary team convenes to reassess the patient's management plan. They explore the feasibility of ECMO as a supportive measure, aiming to provide circulatory and respiratory stabilization while addressing underlying issues. The team also considers the need for continuous renal replacement therapy (CRRT) to manage the escalating metabolic derangements and fluid overload. As the situation becomes increasingly dire, the team prepares for potential rapid interventions, reinforcing the need for continuous monitoring and dynamic clinical decision-making to navigate the patient's complex and evolving condition.